Ultrasonography-guided oral anticoagulant therapy reduced recurrent venous thromboembolism

Bounameaux, Henri; Prandoni, P.; Levi, Marcel; Glynn, R. J.
September 2009
ACP Journal Club;9/22/2009, Vol. 151 Issue 3, p7
Academic Journal
The article presents the findings of a study to assess whether ultrasonography-guided oral anticoagulation therapy (OAT) reduces risk for recurrent venous thromboembolism (VTE). The research was conducted with patients having deep veinous thrombosis (DVT). The study revealed that ultrasonography-guided oral anticoagulant therapy reduced recurrent venous thromboembolism more than fixed-duration therapy.


Related Articles

  • Diagnosis of Suspected Recurrent Deep Venous Thrombosis Using D-Dimer and Compression Ultrasonography. Rathbun, S.W.; Whitsett, T.L.; Raskob, G.E. // Annals of Internal Medicine;12/7/2004, Vol. 141 Issue 11, pI46 

    The article presents queries related to the diagnosis of suspected recurrent deep venous thrombosis (DVT) using D-dimer and compression ultrasonography. DVT occurs when blood clots form in the large veins of the legs. Patients with DVT require treatment with blood thinners to help dissolve the...

  • Inherited thrombophilia and pregnancy associated venous thromboembolism. Lim, Wendy; Eikelboom, John W.; Ginsberg, Jeffrey S. // BMJ: British Medical Journal (International Edition);6/23/2007, Vol. 334 Issue 7607, p1318 

    The article presents an overview of inherited thrombophilia and pregnancy associated with thromboembolism. A discussion of the frequency of thromboembolic complications among pregnant women and risk factors for developing thromboembolism during pregnancy is presented. Common symptoms, including...

  • Time to Cardioversion for Acute Atrial Fibrillation and Thromboembolic Complications. Nuotio, Ilpo; Hartikainen, Juha E. K.; Grönberg, Toni; Biancari, Fausto; Juhani Airaksinen, K. E. // JAMA: Journal of the American Medical Association;8/13/2014, Vol. 312 Issue 6, p647 

    The article discusses the link between thromboembolic complications and the use of atrial fibrillation for cardioversion without anticoagulation in less than 49 hours. Topics mentioned include the definition of a thromboembolic event, details of a trial conducted on patients with a primary...

  • ACTUALITÄ‚Å¢I ÃŽN MANAGEMENTUL RISCULUI TROMBOEMBOLIC LA PACIENÅ¢II CU FIBRILAÅ¢IE ATRIALÄ‚. Orga-Dumitriu, D.; Teodoru, Minodora; Tănăsescu, C.; Teodoru, A. // Acta Medica Transilvanica;sep2012, Vol. 17 Issue 3, p103 

    The therapeutic management of the patients with atrial fibrillation should take into account the risk for thromboembolism, resulted in an incidence of strokes 5 times higher than in the general population. The stratification of this risk is validated by two scoring systems (CHADS2, CHA2DS2-...

  • Low-responders to clopidogrel assessed with MEA have higher risk for stent thrombosis.  // Cardiology Today;Apr2009, Vol. 12 Issue 4, p16 

    The article reports that a recent prospective study has revealed that a low response to clopidogrel therapy measured by multiple electrode platelet aggregometry is associated with an increase in stent thrombosis.

  • Antiplatelet therapy: in search of the 'magic bullet'. Jackson, Shaun P.; Schoenwaelder, Simone M. // Nature Reviews Drug Discovery;Oct2003, Vol. 2 Issue 10, p775 

    The central importance of platelets in the development of arterial thrombosis and cardiovascular disease is well established. No other single cell type is responsible for as much morbidity and mortality as the platelet and, as a consequence, it represents a major target for therapeutic...

  • Venous thromboembolism and anticoagulants in pregnancy.  // British Medical Journal;11/22/1975, Vol. 4 Issue 5994, p421 

    Describes the aspects of venous thromboembolism and anticoagulants in pregnancy. Risk of puerperal venous thromboembolism; Suppression of lactation by estrogens; Frequency of fatal pulmonary embolism.

  • An overview of antithrombotic therapy. Blann, Andrew D; Landray, Martin J; Lip, Gregory Y H // BMJ: British Medical Journal (International Edition);10/5/2002, Vol. 325 Issue 7367, p762 

    Provides an overview of antithrombotic therapy. Clinical problems relating to thrombosis; Cardiovascular disorders associated with it; Factors that influence the efficacy of warfarin; Efficiency of hirduin and direct thrombin inhibitors. INSETS: Contraindications to aspririn;Factors that...

  • INRs and point of care testing. Murray, E. T.; Greaves, M. // BMJ: British Medical Journal (International Edition);7/5/2003, Vol. 327 Issue 7405, p5 

    Reports on the development and adoption of instruments for determining the international normalised ratio (INR) at the point of care for monitoring treatment with coumarin anticoagulants. Use of coumarin anticoagulants in the treatment of thrombosis; How a difference exists between the...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics